nodes	percent_of_prediction	percent_of_DWPC	metapath
Penbutolol—Timolol—coronary artery disease	0.408	1	CrCtD
Penbutolol—Bupranolol—Gemfibrozil—coronary artery disease	0.125	0.531	CrCrCtD
Penbutolol—ADRB1—coronary artery disease	0.092	0.543	CbGaD
Penbutolol—ADRB2—coronary artery disease	0.0774	0.457	CbGaD
Penbutolol—Levobunolol—Timolol—coronary artery disease	0.0641	0.272	CrCrCtD
Penbutolol—Bupranolol—Timolol—coronary artery disease	0.0464	0.197	CrCrCtD
Penbutolol—ORM1—Pitavastatin—coronary artery disease	0.0449	0.43	CbGbCtD
Penbutolol—ADRB2—Timolol—coronary artery disease	0.0299	0.287	CbGbCtD
Penbutolol—ADRB1—Timolol—coronary artery disease	0.0295	0.283	CbGbCtD
Penbutolol—Levobunolol—ADRB1—coronary artery disease	0.000166	0.0878	CrCbGaD
Penbutolol—Timolol—ADRB1—coronary artery disease	0.000158	0.0838	CrCbGaD
Penbutolol—Carteolol—ADRB1—coronary artery disease	0.000141	0.0747	CrCbGaD
Penbutolol—Levobunolol—ADRB2—coronary artery disease	0.000139	0.0739	CrCbGaD
Penbutolol—Timolol—ADRB2—coronary artery disease	0.000133	0.0705	CrCbGaD
Penbutolol—Nadolol—ADRB1—coronary artery disease	0.000125	0.0666	CrCbGaD
Penbutolol—Bupranolol—ADRB1—coronary artery disease	0.00012	0.0635	CrCbGaD
Penbutolol—Carteolol—ADRB2—coronary artery disease	0.000118	0.0628	CrCbGaD
Penbutolol—Timolol—CYP2C19—coronary artery disease	0.000114	0.0607	CrCbGaD
Penbutolol—Nadolol—ADRB2—coronary artery disease	0.000105	0.056	CrCbGaD
Penbutolol—Bupranolol—ADRB2—coronary artery disease	0.000101	0.0534	CrCbGaD
Penbutolol—Oxprenolol—ADRB1—coronary artery disease	0.0001	0.0532	CrCbGaD
Penbutolol—Diarrhoea—Ticagrelor—coronary artery disease	9.48e-05	0.00177	CcSEcCtD
Penbutolol—Agranulocytosis—Ramipril—coronary artery disease	9.47e-05	0.00177	CcSEcCtD
Penbutolol—Dyspnoea—Lovastatin—coronary artery disease	9.42e-05	0.00176	CcSEcCtD
Penbutolol—Alopecia—Losartan—coronary artery disease	9.39e-05	0.00176	CcSEcCtD
Penbutolol—Dizziness—Gemfibrozil—coronary artery disease	9.38e-05	0.00176	CcSEcCtD
Penbutolol—Insomnia—Ezetimibe—coronary artery disease	9.38e-05	0.00175	CcSEcCtD
Penbutolol—Dyspepsia—Clopidogrel—coronary artery disease	9.37e-05	0.00175	CcSEcCtD
Penbutolol—Fatigue—Fenofibrate—coronary artery disease	9.33e-05	0.00175	CcSEcCtD
Penbutolol—Dyspepsia—Lovastatin—coronary artery disease	9.31e-05	0.00174	CcSEcCtD
Penbutolol—Cough—Trandolapril—coronary artery disease	9.28e-05	0.00174	CcSEcCtD
Penbutolol—Agranulocytosis—Timolol—coronary artery disease	9.26e-05	0.00173	CcSEcCtD
Penbutolol—Pain—Fenofibrate—coronary artery disease	9.26e-05	0.00173	CcSEcCtD
Penbutolol—Cough—Enalapril—coronary artery disease	9.24e-05	0.00173	CcSEcCtD
Penbutolol—Dyspnoea—Ezetimibe—coronary artery disease	9.24e-05	0.00173	CcSEcCtD
Penbutolol—Depression—Lisinopril—coronary artery disease	9.18e-05	0.00172	CcSEcCtD
Penbutolol—Insomnia—Eplerenone—coronary artery disease	9.18e-05	0.00172	CcSEcCtD
Penbutolol—Fatigue—Clopidogrel—coronary artery disease	9.17e-05	0.00172	CcSEcCtD
Penbutolol—Alprenolol—ADRB1—coronary artery disease	9.17e-05	0.0487	CrCbGaD
Penbutolol—Dizziness—Ticagrelor—coronary artery disease	9.16e-05	0.00171	CcSEcCtD
Penbutolol—Dyspepsia—Ezetimibe—coronary artery disease	9.13e-05	0.00171	CcSEcCtD
Penbutolol—Cough—Telmisartan—coronary artery disease	9.12e-05	0.00171	CcSEcCtD
Penbutolol—Fatigue—Lovastatin—coronary artery disease	9.11e-05	0.00171	CcSEcCtD
Penbutolol—Pain—Clopidogrel—coronary artery disease	9.1e-05	0.0017	CcSEcCtD
Penbutolol—Bradycardia—Timolol—coronary artery disease	9.07e-05	0.0017	CcSEcCtD
Penbutolol—Dyspnoea—Eplerenone—coronary artery disease	9.05e-05	0.00169	CcSEcCtD
Penbutolol—Pain—Lovastatin—coronary artery disease	9.04e-05	0.00169	CcSEcCtD
Penbutolol—Hyperhidrosis—Olmesartan—coronary artery disease	8.98e-05	0.00168	CcSEcCtD
Penbutolol—Asthenia—Rosuvastatin—coronary artery disease	8.95e-05	0.00167	CcSEcCtD
Penbutolol—Insomnia—Simvastatin—coronary artery disease	8.94e-05	0.00167	CcSEcCtD
Penbutolol—Fatigue—Ezetimibe—coronary artery disease	8.94e-05	0.00167	CcSEcCtD
Penbutolol—Dyspepsia—Eplerenone—coronary artery disease	8.93e-05	0.00167	CcSEcCtD
Penbutolol—Headache—Gemfibrozil—coronary artery disease	8.89e-05	0.00166	CcSEcCtD
Penbutolol—Cough—Captopril—coronary artery disease	8.87e-05	0.00166	CcSEcCtD
Penbutolol—Pain—Ezetimibe—coronary artery disease	8.87e-05	0.00166	CcSEcCtD
Penbutolol—Sweating—Lisinopril—coronary artery disease	8.83e-05	0.00165	CcSEcCtD
Penbutolol—Dyspnoea—Simvastatin—coronary artery disease	8.82e-05	0.00165	CcSEcCtD
Penbutolol—Hyperhidrosis—Niacin—coronary artery disease	8.78e-05	0.00164	CcSEcCtD
Penbutolol—Fatigue—Eplerenone—coronary artery disease	8.75e-05	0.00164	CcSEcCtD
Penbutolol—Dyspepsia—Simvastatin—coronary artery disease	8.7e-05	0.00163	CcSEcCtD
Penbutolol—Headache—Ticagrelor—coronary artery disease	8.68e-05	0.00162	CcSEcCtD
Penbutolol—Pain—Eplerenone—coronary artery disease	8.68e-05	0.00162	CcSEcCtD
Penbutolol—Hyperhidrosis—Pravastatin—coronary artery disease	8.64e-05	0.00162	CcSEcCtD
Penbutolol—Cough—Perindopril—coronary artery disease	8.61e-05	0.00161	CcSEcCtD
Penbutolol—Agranulocytosis—Lisinopril—coronary artery disease	8.59e-05	0.00161	CcSEcCtD
Penbutolol—Body temperature increased—Fenofibrate—coronary artery disease	8.56e-05	0.0016	CcSEcCtD
Penbutolol—Diarrhoea—Rosuvastatin—coronary artery disease	8.53e-05	0.0016	CcSEcCtD
Penbutolol—Fatigue—Simvastatin—coronary artery disease	8.52e-05	0.0016	CcSEcCtD
Penbutolol—Pain—Simvastatin—coronary artery disease	8.46e-05	0.00158	CcSEcCtD
Penbutolol—Insomnia—Valsartan—coronary artery disease	8.45e-05	0.00158	CcSEcCtD
Penbutolol—Oxprenolol—ADRB2—coronary artery disease	8.43e-05	0.0448	CrCbGaD
Penbutolol—Nausea—Gemfibrozil—coronary artery disease	8.43e-05	0.00158	CcSEcCtD
Penbutolol—Bradycardia—Lisinopril—coronary artery disease	8.41e-05	0.00157	CcSEcCtD
Penbutolol—Body temperature increased—Clopidogrel—coronary artery disease	8.41e-05	0.00157	CcSEcCtD
Penbutolol—Insomnia—Olmesartan—coronary artery disease	8.4e-05	0.00157	CcSEcCtD
Penbutolol—Hyperhidrosis—Trandolapril—coronary artery disease	8.39e-05	0.00157	CcSEcCtD
Penbutolol—Hyperhidrosis—Enalapril—coronary artery disease	8.36e-05	0.00156	CcSEcCtD
Penbutolol—Body temperature increased—Lovastatin—coronary artery disease	8.36e-05	0.00156	CcSEcCtD
Penbutolol—Dyspnoea—Valsartan—coronary artery disease	8.32e-05	0.00156	CcSEcCtD
Penbutolol—Diarrhoea—Acetylsalicylic acid—coronary artery disease	8.29e-05	0.00155	CcSEcCtD
Penbutolol—Dizziness—Rosuvastatin—coronary artery disease	8.25e-05	0.00154	CcSEcCtD
Penbutolol—Hyperhidrosis—Telmisartan—coronary artery disease	8.24e-05	0.00154	CcSEcCtD
Penbutolol—Nausea—Ticagrelor—coronary artery disease	8.23e-05	0.00154	CcSEcCtD
Penbutolol—Dyspepsia—Valsartan—coronary artery disease	8.22e-05	0.00154	CcSEcCtD
Penbutolol—Insomnia—Niacin—coronary artery disease	8.21e-05	0.00154	CcSEcCtD
Penbutolol—Body temperature increased—Ezetimibe—coronary artery disease	8.2e-05	0.00153	CcSEcCtD
Penbutolol—Dyspepsia—Olmesartan—coronary artery disease	8.18e-05	0.00153	CcSEcCtD
Penbutolol—Dyspnoea—Niacin—coronary artery disease	8.09e-05	0.00151	CcSEcCtD
Penbutolol—Insomnia—Pravastatin—coronary artery disease	8.09e-05	0.00151	CcSEcCtD
Penbutolol—Cough—Losartan—coronary artery disease	8.07e-05	0.00151	CcSEcCtD
Penbutolol—Alopecia—Ramipril—coronary artery disease	8.05e-05	0.00151	CcSEcCtD
Penbutolol—Fatigue—Valsartan—coronary artery disease	8.05e-05	0.00151	CcSEcCtD
Penbutolol—Body temperature increased—Eplerenone—coronary artery disease	8.02e-05	0.0015	CcSEcCtD
Penbutolol—Dizziness—Acetylsalicylic acid—coronary artery disease	8.01e-05	0.0015	CcSEcCtD
Penbutolol—Fatigue—Olmesartan—coronary artery disease	8.01e-05	0.0015	CcSEcCtD
Penbutolol—Dyspepsia—Niacin—coronary artery disease	7.99e-05	0.0015	CcSEcCtD
Penbutolol—Dyspnoea—Pravastatin—coronary artery disease	7.97e-05	0.00149	CcSEcCtD
Penbutolol—Pain—Olmesartan—coronary artery disease	7.95e-05	0.00149	CcSEcCtD
Penbutolol—Alopecia—Timolol—coronary artery disease	7.87e-05	0.00147	CcSEcCtD
Penbutolol—Dyspepsia—Pravastatin—coronary artery disease	7.87e-05	0.00147	CcSEcCtD
Penbutolol—Insomnia—Trandolapril—coronary artery disease	7.85e-05	0.00147	CcSEcCtD
Penbutolol—Insomnia—Enalapril—coronary artery disease	7.82e-05	0.00146	CcSEcCtD
Penbutolol—Body temperature increased—Simvastatin—coronary artery disease	7.82e-05	0.00146	CcSEcCtD
Penbutolol—Headache—Rosuvastatin—coronary artery disease	7.81e-05	0.00146	CcSEcCtD
Penbutolol—Hyperhidrosis—Perindopril—coronary artery disease	7.78e-05	0.00146	CcSEcCtD
Penbutolol—Asthenia—Fenofibrate—coronary artery disease	7.77e-05	0.00145	CcSEcCtD
Penbutolol—Pain—Niacin—coronary artery disease	7.76e-05	0.00145	CcSEcCtD
Penbutolol—Dyspnoea—Trandolapril—coronary artery disease	7.74e-05	0.00145	CcSEcCtD
Penbutolol—Insomnia—Telmisartan—coronary artery disease	7.71e-05	0.00144	CcSEcCtD
Penbutolol—Alprenolol—ADRB2—coronary artery disease	7.71e-05	0.0409	CrCbGaD
Penbutolol—Dyspnoea—Enalapril—coronary artery disease	7.71e-05	0.00144	CcSEcCtD
Penbutolol—Fatigue—Pravastatin—coronary artery disease	7.71e-05	0.00144	CcSEcCtD
Penbutolol—Pain—Pravastatin—coronary artery disease	7.64e-05	0.00143	CcSEcCtD
Penbutolol—Dyspepsia—Trandolapril—coronary artery disease	7.64e-05	0.00143	CcSEcCtD
Penbutolol—Asthenia—Clopidogrel—coronary artery disease	7.64e-05	0.00143	CcSEcCtD
Penbutolol—Dyspepsia—Enalapril—coronary artery disease	7.61e-05	0.00142	CcSEcCtD
Penbutolol—Dyspnoea—Telmisartan—coronary artery disease	7.6e-05	0.00142	CcSEcCtD
Penbutolol—Asthenia—Lovastatin—coronary artery disease	7.58e-05	0.00142	CcSEcCtD
Penbutolol—Hyperhidrosis—Furosemide—coronary artery disease	7.57e-05	0.00142	CcSEcCtD
Penbutolol—Dyspepsia—Telmisartan—coronary artery disease	7.51e-05	0.0014	CcSEcCtD
Penbutolol—Insomnia—Captopril—coronary artery disease	7.5e-05	0.0014	CcSEcCtD
Penbutolol—Fatigue—Trandolapril—coronary artery disease	7.48e-05	0.0014	CcSEcCtD
Penbutolol—Fatigue—Enalapril—coronary artery disease	7.45e-05	0.00139	CcSEcCtD
Penbutolol—Asthenia—Ezetimibe—coronary artery disease	7.44e-05	0.00139	CcSEcCtD
Penbutolol—Nausea—Rosuvastatin—coronary artery disease	7.41e-05	0.00139	CcSEcCtD
Penbutolol—Diarrhoea—Fenofibrate—coronary artery disease	7.41e-05	0.00139	CcSEcCtD
Penbutolol—Dyspnoea—Captopril—coronary artery disease	7.39e-05	0.00138	CcSEcCtD
Penbutolol—Fatigue—Telmisartan—coronary artery disease	7.35e-05	0.00138	CcSEcCtD
Penbutolol—Body temperature increased—Olmesartan—coronary artery disease	7.35e-05	0.00137	CcSEcCtD
Penbutolol—Alopecia—Lisinopril—coronary artery disease	7.3e-05	0.00137	CcSEcCtD
Penbutolol—Hyperhidrosis—Losartan—coronary artery disease	7.3e-05	0.00137	CcSEcCtD
Penbutolol—Dyspepsia—Captopril—coronary artery disease	7.3e-05	0.00137	CcSEcCtD
Penbutolol—Pain—Telmisartan—coronary artery disease	7.29e-05	0.00136	CcSEcCtD
Penbutolol—Insomnia—Perindopril—coronary artery disease	7.28e-05	0.00136	CcSEcCtD
Penbutolol—Diarrhoea—Clopidogrel—coronary artery disease	7.28e-05	0.00136	CcSEcCtD
Penbutolol—Asthenia—Eplerenone—coronary artery disease	7.28e-05	0.00136	CcSEcCtD
Penbutolol—Diarrhoea—Lovastatin—coronary artery disease	7.23e-05	0.00135	CcSEcCtD
Penbutolol—Nausea—Acetylsalicylic acid—coronary artery disease	7.2e-05	0.00135	CcSEcCtD
Penbutolol—Dyspnoea—Perindopril—coronary artery disease	7.18e-05	0.00134	CcSEcCtD
Penbutolol—Body temperature increased—Niacin—coronary artery disease	7.18e-05	0.00134	CcSEcCtD
Penbutolol—Dizziness—Fenofibrate—coronary artery disease	7.16e-05	0.00134	CcSEcCtD
Penbutolol—Fatigue—Captopril—coronary artery disease	7.15e-05	0.00134	CcSEcCtD
Penbutolol—Asthenia—Simvastatin—coronary artery disease	7.09e-05	0.00133	CcSEcCtD
Penbutolol—Diarrhoea—Ezetimibe—coronary artery disease	7.09e-05	0.00133	CcSEcCtD
Penbutolol—Dyspepsia—Perindopril—coronary artery disease	7.09e-05	0.00133	CcSEcCtD
Penbutolol—Body temperature increased—Pravastatin—coronary artery disease	7.07e-05	0.00132	CcSEcCtD
Penbutolol—Dizziness—Clopidogrel—coronary artery disease	7.04e-05	0.00132	CcSEcCtD
Penbutolol—Dizziness—Lovastatin—coronary artery disease	6.99e-05	0.00131	CcSEcCtD
Penbutolol—Diarrhoea—Eplerenone—coronary artery disease	6.94e-05	0.0013	CcSEcCtD
Penbutolol—Fatigue—Perindopril—coronary artery disease	6.94e-05	0.0013	CcSEcCtD
Penbutolol—Cough—Ramipril—coronary artery disease	6.92e-05	0.0013	CcSEcCtD
Penbutolol—Pain—Perindopril—coronary artery disease	6.88e-05	0.00129	CcSEcCtD
Penbutolol—Body temperature increased—Trandolapril—coronary artery disease	6.86e-05	0.00128	CcSEcCtD
Penbutolol—Dizziness—Ezetimibe—coronary artery disease	6.86e-05	0.00128	CcSEcCtD
Penbutolol—Body temperature increased—Enalapril—coronary artery disease	6.83e-05	0.00128	CcSEcCtD
Penbutolol—Insomnia—Losartan—coronary artery disease	6.83e-05	0.00128	CcSEcCtD
Penbutolol—Headache—Fenofibrate—coronary artery disease	6.78e-05	0.00127	CcSEcCtD
Penbutolol—Cough—Timolol—coronary artery disease	6.77e-05	0.00127	CcSEcCtD
Penbutolol—Diarrhoea—Simvastatin—coronary artery disease	6.77e-05	0.00127	CcSEcCtD
Penbutolol—Fatigue—Furosemide—coronary artery disease	6.75e-05	0.00126	CcSEcCtD
Penbutolol—Body temperature increased—Telmisartan—coronary artery disease	6.74e-05	0.00126	CcSEcCtD
Penbutolol—Dyspnoea—Losartan—coronary artery disease	6.73e-05	0.00126	CcSEcCtD
Penbutolol—Dizziness—Eplerenone—coronary artery disease	6.71e-05	0.00126	CcSEcCtD
Penbutolol—Asthenia—Valsartan—coronary artery disease	6.7e-05	0.00125	CcSEcCtD
Penbutolol—Pain—Furosemide—coronary artery disease	6.69e-05	0.00125	CcSEcCtD
Penbutolol—Asthenia—Olmesartan—coronary artery disease	6.67e-05	0.00125	CcSEcCtD
Penbutolol—Headache—Clopidogrel—coronary artery disease	6.67e-05	0.00125	CcSEcCtD
Penbutolol—Dyspepsia—Losartan—coronary artery disease	6.65e-05	0.00124	CcSEcCtD
Penbutolol—Headache—Lovastatin—coronary artery disease	6.62e-05	0.00124	CcSEcCtD
Penbutolol—Body temperature increased—Captopril—coronary artery disease	6.56e-05	0.00123	CcSEcCtD
Penbutolol—Dizziness—Simvastatin—coronary artery disease	6.54e-05	0.00122	CcSEcCtD
Penbutolol—Asthenia—Niacin—coronary artery disease	6.51e-05	0.00122	CcSEcCtD
Penbutolol—Fatigue—Losartan—coronary artery disease	6.51e-05	0.00122	CcSEcCtD
Penbutolol—Headache—Ezetimibe—coronary artery disease	6.5e-05	0.00122	CcSEcCtD
Penbutolol—Pain—Losartan—coronary artery disease	6.46e-05	0.00121	CcSEcCtD
Penbutolol—Nausea—Fenofibrate—coronary artery disease	6.43e-05	0.0012	CcSEcCtD
Penbutolol—Asthenia—Pravastatin—coronary artery disease	6.41e-05	0.0012	CcSEcCtD
Penbutolol—Diarrhoea—Valsartan—coronary artery disease	6.39e-05	0.0012	CcSEcCtD
Penbutolol—Body temperature increased—Perindopril—coronary artery disease	6.36e-05	0.00119	CcSEcCtD
Penbutolol—Diarrhoea—Olmesartan—coronary artery disease	6.36e-05	0.00119	CcSEcCtD
Penbutolol—Headache—Eplerenone—coronary artery disease	6.36e-05	0.00119	CcSEcCtD
Penbutolol—Nausea—Clopidogrel—coronary artery disease	6.32e-05	0.00118	CcSEcCtD
Penbutolol—Cough—Lisinopril—coronary artery disease	6.28e-05	0.00118	CcSEcCtD
Penbutolol—Nausea—Lovastatin—coronary artery disease	6.28e-05	0.00118	CcSEcCtD
Penbutolol—Hyperhidrosis—Ramipril—coronary artery disease	6.26e-05	0.00117	CcSEcCtD
Penbutolol—Asthenia—Trandolapril—coronary artery disease	6.23e-05	0.00117	CcSEcCtD
Penbutolol—Diarrhoea—Niacin—coronary artery disease	6.21e-05	0.00116	CcSEcCtD
Penbutolol—Asthenia—Enalapril—coronary artery disease	6.2e-05	0.00116	CcSEcCtD
Penbutolol—Headache—Simvastatin—coronary artery disease	6.19e-05	0.00116	CcSEcCtD
Penbutolol—Body temperature increased—Furosemide—coronary artery disease	6.19e-05	0.00116	CcSEcCtD
Penbutolol—Dizziness—Valsartan—coronary artery disease	6.17e-05	0.00116	CcSEcCtD
Penbutolol—Nausea—Ezetimibe—coronary artery disease	6.16e-05	0.00115	CcSEcCtD
Penbutolol—Dizziness—Olmesartan—coronary artery disease	6.14e-05	0.00115	CcSEcCtD
Penbutolol—Hyperhidrosis—Timolol—coronary artery disease	6.12e-05	0.00115	CcSEcCtD
Penbutolol—Asthenia—Telmisartan—coronary artery disease	6.12e-05	0.00114	CcSEcCtD
Penbutolol—Diarrhoea—Pravastatin—coronary artery disease	6.12e-05	0.00114	CcSEcCtD
Penbutolol—Nausea—Eplerenone—coronary artery disease	6.03e-05	0.00113	CcSEcCtD
Penbutolol—Dizziness—Niacin—coronary artery disease	6e-05	0.00112	CcSEcCtD
Penbutolol—Body temperature increased—Losartan—coronary artery disease	5.97e-05	0.00112	CcSEcCtD
Penbutolol—Asthenia—Captopril—coronary artery disease	5.95e-05	0.00111	CcSEcCtD
Penbutolol—Diarrhoea—Trandolapril—coronary artery disease	5.94e-05	0.00111	CcSEcCtD
Penbutolol—Diarrhoea—Enalapril—coronary artery disease	5.92e-05	0.00111	CcSEcCtD
Penbutolol—Dizziness—Pravastatin—coronary artery disease	5.91e-05	0.00111	CcSEcCtD
Penbutolol—Nausea—Simvastatin—coronary artery disease	5.87e-05	0.0011	CcSEcCtD
Penbutolol—Insomnia—Ramipril—coronary artery disease	5.86e-05	0.0011	CcSEcCtD
Penbutolol—Headache—Valsartan—coronary artery disease	5.85e-05	0.00109	CcSEcCtD
Penbutolol—Diarrhoea—Telmisartan—coronary artery disease	5.83e-05	0.00109	CcSEcCtD
Penbutolol—Headache—Olmesartan—coronary artery disease	5.82e-05	0.00109	CcSEcCtD
Penbutolol—Asthenia—Perindopril—coronary artery disease	5.78e-05	0.00108	CcSEcCtD
Penbutolol—Dyspnoea—Ramipril—coronary artery disease	5.77e-05	0.00108	CcSEcCtD
Penbutolol—Dizziness—Trandolapril—coronary artery disease	5.74e-05	0.00107	CcSEcCtD
Penbutolol—Insomnia—Timolol—coronary artery disease	5.73e-05	0.00107	CcSEcCtD
Penbutolol—Dizziness—Enalapril—coronary artery disease	5.72e-05	0.00107	CcSEcCtD
Penbutolol—Dyspepsia—Ramipril—coronary artery disease	5.7e-05	0.00107	CcSEcCtD
Penbutolol—Headache—Niacin—coronary artery disease	5.69e-05	0.00106	CcSEcCtD
Penbutolol—Hyperhidrosis—Lisinopril—coronary artery disease	5.68e-05	0.00106	CcSEcCtD
Penbutolol—Diarrhoea—Captopril—coronary artery disease	5.67e-05	0.00106	CcSEcCtD
Penbutolol—Dyspnoea—Timolol—coronary artery disease	5.64e-05	0.00106	CcSEcCtD
Penbutolol—Dizziness—Telmisartan—coronary artery disease	5.64e-05	0.00106	CcSEcCtD
Penbutolol—Asthenia—Furosemide—coronary artery disease	5.62e-05	0.00105	CcSEcCtD
Penbutolol—Headache—Pravastatin—coronary artery disease	5.6e-05	0.00105	CcSEcCtD
Penbutolol—Fatigue—Ramipril—coronary artery disease	5.58e-05	0.00104	CcSEcCtD
Penbutolol—Dyspepsia—Timolol—coronary artery disease	5.57e-05	0.00104	CcSEcCtD
Penbutolol—Nausea—Valsartan—coronary artery disease	5.55e-05	0.00104	CcSEcCtD
Penbutolol—Nausea—Olmesartan—coronary artery disease	5.52e-05	0.00103	CcSEcCtD
Penbutolol—Diarrhoea—Perindopril—coronary artery disease	5.51e-05	0.00103	CcSEcCtD
Penbutolol—Dizziness—Captopril—coronary artery disease	5.48e-05	0.00103	CcSEcCtD
Penbutolol—Fatigue—Timolol—coronary artery disease	5.46e-05	0.00102	CcSEcCtD
Penbutolol—Headache—Trandolapril—coronary artery disease	5.44e-05	0.00102	CcSEcCtD
Penbutolol—Asthenia—Losartan—coronary artery disease	5.42e-05	0.00101	CcSEcCtD
Penbutolol—Headache—Enalapril—coronary artery disease	5.42e-05	0.00101	CcSEcCtD
Penbutolol—Pain—Timolol—coronary artery disease	5.41e-05	0.00101	CcSEcCtD
Penbutolol—Nausea—Niacin—coronary artery disease	5.39e-05	0.00101	CcSEcCtD
Penbutolol—Diarrhoea—Furosemide—coronary artery disease	5.36e-05	0.001	CcSEcCtD
Penbutolol—Headache—Telmisartan—coronary artery disease	5.34e-05	0.001	CcSEcCtD
Penbutolol—Dizziness—Perindopril—coronary artery disease	5.32e-05	0.000996	CcSEcCtD
Penbutolol—Insomnia—Lisinopril—coronary artery disease	5.31e-05	0.000994	CcSEcCtD
Penbutolol—Nausea—Pravastatin—coronary artery disease	5.31e-05	0.000994	CcSEcCtD
Penbutolol—Dyspnoea—Lisinopril—coronary artery disease	5.24e-05	0.00098	CcSEcCtD
Penbutolol—Headache—Captopril—coronary artery disease	5.19e-05	0.000972	CcSEcCtD
Penbutolol—Dizziness—Furosemide—coronary artery disease	5.18e-05	0.000969	CcSEcCtD
Penbutolol—Dyspepsia—Lisinopril—coronary artery disease	5.17e-05	0.000967	CcSEcCtD
Penbutolol—Diarrhoea—Losartan—coronary artery disease	5.17e-05	0.000967	CcSEcCtD
Penbutolol—Nausea—Trandolapril—coronary artery disease	5.16e-05	0.000965	CcSEcCtD
Penbutolol—Nausea—Enalapril—coronary artery disease	5.14e-05	0.000961	CcSEcCtD
Penbutolol—Body temperature increased—Ramipril—coronary artery disease	5.12e-05	0.000958	CcSEcCtD
Penbutolol—Nausea—Telmisartan—coronary artery disease	5.07e-05	0.000948	CcSEcCtD
Penbutolol—Fatigue—Lisinopril—coronary artery disease	5.06e-05	0.000947	CcSEcCtD
Penbutolol—Headache—Perindopril—coronary artery disease	5.04e-05	0.000944	CcSEcCtD
Penbutolol—Pain—Lisinopril—coronary artery disease	5.02e-05	0.00094	CcSEcCtD
Penbutolol—Body temperature increased—Timolol—coronary artery disease	5e-05	0.000936	CcSEcCtD
Penbutolol—Dizziness—Losartan—coronary artery disease	4.99e-05	0.000935	CcSEcCtD
Penbutolol—Nausea—Captopril—coronary artery disease	4.93e-05	0.000922	CcSEcCtD
Penbutolol—Headache—Furosemide—coronary artery disease	4.9e-05	0.000918	CcSEcCtD
Penbutolol—Nausea—Perindopril—coronary artery disease	4.78e-05	0.000895	CcSEcCtD
Penbutolol—Headache—Losartan—coronary artery disease	4.73e-05	0.000885	CcSEcCtD
Penbutolol—Nausea—Furosemide—coronary artery disease	4.65e-05	0.00087	CcSEcCtD
Penbutolol—Asthenia—Ramipril—coronary artery disease	4.65e-05	0.000869	CcSEcCtD
Penbutolol—Body temperature increased—Lisinopril—coronary artery disease	4.64e-05	0.000869	CcSEcCtD
Penbutolol—Asthenia—Timolol—coronary artery disease	4.54e-05	0.00085	CcSEcCtD
Penbutolol—Nausea—Losartan—coronary artery disease	4.49e-05	0.000839	CcSEcCtD
Penbutolol—Diarrhoea—Ramipril—coronary artery disease	4.43e-05	0.000829	CcSEcCtD
Penbutolol—Diarrhoea—Timolol—coronary artery disease	4.33e-05	0.000811	CcSEcCtD
Penbutolol—Propranolol—ADRB1—coronary artery disease	4.3e-05	0.0228	CrCbGaD
Penbutolol—Dizziness—Ramipril—coronary artery disease	4.28e-05	0.000801	CcSEcCtD
Penbutolol—Asthenia—Lisinopril—coronary artery disease	4.21e-05	0.000788	CcSEcCtD
Penbutolol—Dizziness—Timolol—coronary artery disease	4.19e-05	0.000783	CcSEcCtD
Penbutolol—Headache—Ramipril—coronary artery disease	4.06e-05	0.000759	CcSEcCtD
Penbutolol—Diarrhoea—Lisinopril—coronary artery disease	4.02e-05	0.000752	CcSEcCtD
Penbutolol—Headache—Timolol—coronary artery disease	3.97e-05	0.000742	CcSEcCtD
Penbutolol—Dizziness—Lisinopril—coronary artery disease	3.88e-05	0.000727	CcSEcCtD
Penbutolol—Nausea—Ramipril—coronary artery disease	3.85e-05	0.00072	CcSEcCtD
Penbutolol—Nausea—Timolol—coronary artery disease	3.76e-05	0.000704	CcSEcCtD
Penbutolol—Headache—Lisinopril—coronary artery disease	3.68e-05	0.000688	CcSEcCtD
Penbutolol—Propranolol—ADRB2—coronary artery disease	3.62e-05	0.0192	CrCbGaD
Penbutolol—Nausea—Lisinopril—coronary artery disease	3.49e-05	0.000653	CcSEcCtD
Penbutolol—Propranolol—CYP2C19—coronary artery disease	3.12e-05	0.0165	CrCbGaD
Penbutolol—HTR1B—Signaling Pathways—PPP2CA—coronary artery disease	3.25e-06	0.000117	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ITGAV—coronary artery disease	3.23e-06	0.000117	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—KNG1—coronary artery disease	3.22e-06	0.000116	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CCL2—coronary artery disease	3.21e-06	0.000116	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—POMC—coronary artery disease	3.21e-06	0.000116	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CREB1—coronary artery disease	3.21e-06	0.000116	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL6R—coronary artery disease	3.2e-06	0.000116	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AGTR1—coronary artery disease	3.2e-06	0.000115	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CXCL10—coronary artery disease	3.2e-06	0.000115	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PLG—coronary artery disease	3.19e-06	0.000115	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PRKCD—coronary artery disease	3.19e-06	0.000115	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ADRB2—coronary artery disease	3.18e-06	0.000115	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CCL2—coronary artery disease	3.14e-06	0.000113	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PRKCE—coronary artery disease	3.14e-06	0.000113	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—JAK2—coronary artery disease	3.13e-06	0.000113	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL6R—coronary artery disease	3.13e-06	0.000113	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CXCL10—coronary artery disease	3.13e-06	0.000113	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SOCS1—coronary artery disease	3.13e-06	0.000113	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PLG—coronary artery disease	3.12e-06	0.000113	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—S100B—coronary artery disease	3.12e-06	0.000113	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—HTR2A—coronary artery disease	3.12e-06	0.000112	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—C3—coronary artery disease	3.11e-06	0.000112	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SOCS3—coronary artery disease	3.09e-06	0.000111	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PRKCE—coronary artery disease	3.07e-06	0.000111	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—JAK2—coronary artery disease	3.07e-06	0.000111	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SOCS1—coronary artery disease	3.06e-06	0.00011	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—KITLG—coronary artery disease	3.05e-06	0.00011	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TGFBR2—coronary artery disease	3.05e-06	0.00011	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—S100B—coronary artery disease	3.05e-06	0.00011	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ADRB2—coronary artery disease	3.04e-06	0.00011	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SOCS3—coronary artery disease	3.02e-06	0.000109	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PRKCE—coronary artery disease	3e-06	0.000108	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—JAK2—coronary artery disease	3e-06	0.000108	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SOCS1—coronary artery disease	2.99e-06	0.000108	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—KITLG—coronary artery disease	2.99e-06	0.000108	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TGFBR2—coronary artery disease	2.99e-06	0.000108	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—S100B—coronary artery disease	2.99e-06	0.000108	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MMP3—coronary artery disease	2.99e-06	0.000108	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—STAT5A—coronary artery disease	2.99e-06	0.000108	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—HIF1A—coronary artery disease	2.97e-06	0.000107	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AGT—coronary artery disease	2.96e-06	0.000107	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SOCS3—coronary artery disease	2.96e-06	0.000107	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—KITLG—coronary artery disease	2.92e-06	0.000105	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TGFBR2—coronary artery disease	2.92e-06	0.000105	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—STAT5A—coronary artery disease	2.92e-06	0.000105	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MMP3—coronary artery disease	2.92e-06	0.000105	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—APOE—coronary artery disease	2.9e-06	0.000105	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—LEP—coronary artery disease	2.9e-06	0.000105	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—APOB—coronary artery disease	2.89e-06	0.000104	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—APOA1—coronary artery disease	2.87e-06	0.000103	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—CXCL8—coronary artery disease	2.86e-06	0.000103	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—STAT5A—coronary artery disease	2.86e-06	0.000103	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MMP3—coronary artery disease	2.86e-06	0.000103	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—JAK2—coronary artery disease	2.85e-06	0.000103	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—KDR—coronary artery disease	2.84e-06	0.000102	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—EDN1—coronary artery disease	2.84e-06	0.000102	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—APOB—coronary artery disease	2.82e-06	0.000102	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MAPK14—coronary artery disease	2.82e-06	0.000102	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCL5—coronary artery disease	2.82e-06	0.000102	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—CXCL8—coronary artery disease	2.8e-06	0.000101	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—JAK2—coronary artery disease	2.78e-06	0.0001	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—EDN1—coronary artery disease	2.78e-06	0.0001	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CSF2—coronary artery disease	2.78e-06	0.0001	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FGF1—coronary artery disease	2.78e-06	0.0001	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—ESR1—coronary artery disease	2.77e-06	9.98e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—APOB—coronary artery disease	2.76e-06	9.95e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCL5—coronary artery disease	2.76e-06	9.94e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—LPL—coronary artery disease	2.76e-06	9.93e-05	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—CXCL8—coronary artery disease	2.74e-06	9.86e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—F2—coronary artery disease	2.73e-06	9.86e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—FN1—coronary artery disease	2.73e-06	9.86e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—RPS6KB1—coronary artery disease	2.73e-06	9.84e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MEF2C—coronary artery disease	2.73e-06	9.84e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL6ST—coronary artery disease	2.72e-06	9.82e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—JAK2—coronary artery disease	2.72e-06	9.82e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—EDN1—coronary artery disease	2.72e-06	9.79e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CSF2—coronary artery disease	2.72e-06	9.79e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FGF1—coronary artery disease	2.72e-06	9.79e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NFKBIA—coronary artery disease	2.7e-06	9.74e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—LPL—coronary artery disease	2.7e-06	9.72e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCL5—coronary artery disease	2.7e-06	9.72e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MEF2C—coronary artery disease	2.67e-06	9.63e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—RPS6KB1—coronary artery disease	2.67e-06	9.63e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ITGB3—coronary artery disease	2.66e-06	9.59e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FGF1—coronary artery disease	2.65e-06	9.57e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CSF2—coronary artery disease	2.65e-06	9.57e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—LPL—coronary artery disease	2.64e-06	9.5e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—KIT—coronary artery disease	2.62e-06	9.43e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MEF2C—coronary artery disease	2.61e-06	9.42e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—RPS6KB1—coronary artery disease	2.61e-06	9.42e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ITGB3—coronary artery disease	2.6e-06	9.38e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—CXCL8—coronary artery disease	2.6e-06	9.37e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PPP2CA—coronary artery disease	2.59e-06	9.32e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ITGB3—coronary artery disease	2.55e-06	9.18e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—CXCL8—coronary artery disease	2.54e-06	9.16e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PRKCD—coronary artery disease	2.54e-06	9.15e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PPP2CA—coronary artery disease	2.53e-06	9.12e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—GSK3B—coronary artery disease	2.51e-06	9.05e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—POMC—coronary artery disease	2.49e-06	8.98e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CREB1—coronary artery disease	2.49e-06	8.98e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—CXCL8—coronary artery disease	2.49e-06	8.96e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—HTR2A—coronary artery disease	2.48e-06	8.95e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PRKCD—coronary artery disease	2.48e-06	8.95e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—C3—coronary artery disease	2.48e-06	8.94e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PPP2CA—coronary artery disease	2.47e-06	8.91e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCL2—coronary artery disease	2.44e-06	8.79e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—HTR2A—coronary artery disease	2.43e-06	8.76e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL6R—coronary artery disease	2.43e-06	8.76e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PRKCD—coronary artery disease	2.43e-06	8.75e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—C3—coronary artery disease	2.43e-06	8.75e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IGF1—coronary artery disease	2.4e-06	8.64e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—MAPK1—coronary artery disease	2.38e-06	8.6e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—HTR2A—coronary artery disease	2.38e-06	8.57e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—C3—coronary artery disease	2.37e-06	8.55e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—HIF1A—coronary artery disease	2.37e-06	8.53e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AGT—coronary artery disease	2.36e-06	8.5e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—HIF1A—coronary artery disease	2.31e-06	8.34e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—APOE—coronary artery disease	2.31e-06	8.33e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—LEP—coronary artery disease	2.31e-06	8.33e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AGT—coronary artery disease	2.31e-06	8.31e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—APOA1—coronary artery disease	2.28e-06	8.23e-05	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—PIK3CA—coronary artery disease	2.28e-06	8.21e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—SERPINE1—coronary artery disease	2.28e-06	8.2e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—HIF1A—coronary artery disease	2.26e-06	8.16e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—KDR—coronary artery disease	2.26e-06	8.16e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—APOE—coronary artery disease	2.26e-06	8.14e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—LEP—coronary artery disease	2.26e-06	8.14e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AGT—coronary artery disease	2.25e-06	8.13e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MAPK14—coronary artery disease	2.25e-06	8.1e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—APOA1—coronary artery disease	2.23e-06	8.05e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—KDR—coronary artery disease	2.21e-06	7.98e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—APOE—coronary artery disease	2.21e-06	7.96e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—LEP—coronary artery disease	2.21e-06	7.96e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—ESR1—coronary artery disease	2.2e-06	7.95e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—FGF2—coronary artery disease	2.2e-06	7.94e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MAPK14—coronary artery disease	2.2e-06	7.93e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—APOA1—coronary artery disease	2.18e-06	7.87e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FN1—coronary artery disease	2.18e-06	7.85e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—F2—coronary artery disease	2.18e-06	7.85e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—NOS3—coronary artery disease	2.17e-06	7.83e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL6ST—coronary artery disease	2.17e-06	7.82e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—KDR—coronary artery disease	2.16e-06	7.8e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—ESR1—coronary artery disease	2.16e-06	7.78e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NFKBIA—coronary artery disease	2.15e-06	7.76e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MAPK14—coronary artery disease	2.15e-06	7.75e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—F2—coronary artery disease	2.13e-06	7.68e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FN1—coronary artery disease	2.13e-06	7.68e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL6ST—coronary artery disease	2.12e-06	7.65e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—JAK2—coronary artery disease	2.11e-06	7.61e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—ESR1—coronary artery disease	2.11e-06	7.6e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NFKBIA—coronary artery disease	2.11e-06	7.59e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—KIT—coronary artery disease	2.08e-06	7.51e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FN1—coronary artery disease	2.08e-06	7.51e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—F2—coronary artery disease	2.08e-06	7.51e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL6ST—coronary artery disease	2.07e-06	7.48e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—PIK3CA—coronary artery disease	2.07e-06	7.46e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NFKBIA—coronary artery disease	2.06e-06	7.42e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—KIT—coronary artery disease	2.04e-06	7.35e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—GSK3B—coronary artery disease	2e-06	7.21e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—KIT—coronary artery disease	1.99e-06	7.19e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CREB1—coronary artery disease	1.98e-06	7.15e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—POMC—coronary artery disease	1.98e-06	7.15e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—GSK3B—coronary artery disease	1.96e-06	7.05e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCL2—coronary artery disease	1.94e-06	7e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—POMC—coronary artery disease	1.94e-06	7e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CREB1—coronary artery disease	1.94e-06	7e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL6R—coronary artery disease	1.94e-06	6.98e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CXCL8—coronary artery disease	1.93e-06	6.95e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—GSK3B—coronary artery disease	1.91e-06	6.9e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IGF1—coronary artery disease	1.91e-06	6.88e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—MAPK1—coronary artery disease	1.9e-06	6.85e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCL2—coronary artery disease	1.9e-06	6.85e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—POMC—coronary artery disease	1.9e-06	6.84e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CREB1—coronary artery disease	1.9e-06	6.84e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL6R—coronary artery disease	1.89e-06	6.82e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IGF1—coronary artery disease	1.87e-06	6.73e-05	CbGpPWpGaD
Penbutolol—HTR1B—GPCR downstream signaling—AKT1—coronary artery disease	1.86e-06	6.71e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—MAPK1—coronary artery disease	1.86e-06	6.7e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCL2—coronary artery disease	1.86e-06	6.69e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL6R—coronary artery disease	1.85e-06	6.67e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CASP3—coronary artery disease	1.84e-06	6.65e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—IL6—coronary artery disease	1.83e-06	6.61e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IGF1—coronary artery disease	1.83e-06	6.58e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—MAPK1—coronary artery disease	1.82e-06	6.55e-05	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—PIK3CA—coronary artery disease	1.81e-06	6.54e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—SERPINE1—coronary artery disease	1.81e-06	6.53e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—CCND1—coronary artery disease	1.8e-06	6.47e-05	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—PIK3CA—coronary artery disease	1.78e-06	6.4e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—SERPINE1—coronary artery disease	1.77e-06	6.39e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—FGF2—coronary artery disease	1.75e-06	6.32e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MMP9—coronary artery disease	1.74e-06	6.28e-05	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—PIK3CA—coronary artery disease	1.74e-06	6.26e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—SERPINE1—coronary artery disease	1.73e-06	6.25e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—NOS3—coronary artery disease	1.73e-06	6.24e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—FGF2—coronary artery disease	1.72e-06	6.19e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—NOS3—coronary artery disease	1.69e-06	6.1e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling by GPCR—AKT1—coronary artery disease	1.69e-06	6.09e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—JAK2—coronary artery disease	1.68e-06	6.06e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—FGF2—coronary artery disease	1.68e-06	6.05e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—NOS3—coronary artery disease	1.65e-06	5.97e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—PIK3CA—coronary artery disease	1.65e-06	5.94e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—JAK2—coronary artery disease	1.64e-06	5.93e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—PIK3CA—coronary artery disease	1.61e-06	5.81e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—JAK2—coronary artery disease	1.61e-06	5.8e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—PIK3CA—coronary artery disease	1.58e-06	5.68e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—VEGFA—coronary artery disease	1.57e-06	5.64e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CXCL8—coronary artery disease	1.53e-06	5.53e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CXCL8—coronary artery disease	1.5e-06	5.41e-05	CbGpPWpGaD
Penbutolol—ADRB1—GPCR downstream signaling—AKT1—coronary artery disease	1.48e-06	5.34e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CASP3—coronary artery disease	1.47e-06	5.3e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CXCL8—coronary artery disease	1.47e-06	5.29e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—IL6—coronary artery disease	1.46e-06	5.26e-05	CbGpPWpGaD
Penbutolol—ADRB2—GPCR downstream signaling—AKT1—coronary artery disease	1.45e-06	5.23e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CASP3—coronary artery disease	1.44e-06	5.18e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—TGFB1—coronary artery disease	1.44e-06	5.18e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—CCND1—coronary artery disease	1.43e-06	5.15e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—IL6—coronary artery disease	1.43e-06	5.15e-05	CbGpPWpGaD
Penbutolol—HTR1A—GPCR downstream signaling—AKT1—coronary artery disease	1.42e-06	5.11e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—MAPK1—coronary artery disease	1.41e-06	5.08e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CASP3—coronary artery disease	1.41e-06	5.06e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—CCND1—coronary artery disease	1.4e-06	5.04e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—IL6—coronary artery disease	1.4e-06	5.03e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MMP9—coronary artery disease	1.39e-06	5e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—CCND1—coronary artery disease	1.37e-06	4.93e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MMP9—coronary artery disease	1.36e-06	4.89e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling by GPCR—AKT1—coronary artery disease	1.35e-06	4.85e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MMP9—coronary artery disease	1.33e-06	4.79e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling by GPCR—AKT1—coronary artery disease	1.32e-06	4.75e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling by GPCR—AKT1—coronary artery disease	1.29e-06	4.64e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—VEGFA—coronary artery disease	1.25e-06	4.49e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—PIK3CA—coronary artery disease	1.22e-06	4.41e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—VEGFA—coronary artery disease	1.22e-06	4.4e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—VEGFA—coronary artery disease	1.19e-06	4.3e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—TGFB1—coronary artery disease	1.14e-06	4.12e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—MAPK1—coronary artery disease	1.12e-06	4.04e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—TGFB1—coronary artery disease	1.12e-06	4.03e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—MAPK1—coronary artery disease	1.1e-06	3.96e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—TGFB1—coronary artery disease	1.09e-06	3.94e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—IL6—coronary artery disease	1.08e-06	3.9e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—MAPK1—coronary artery disease	1.07e-06	3.87e-05	CbGpPWpGaD
Penbutolol—HTR1B—Signaling Pathways—AKT1—coronary artery disease	9.99e-07	3.6e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—PIK3CA—coronary artery disease	9.74e-07	3.51e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—PIK3CA—coronary artery disease	9.52e-07	3.43e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—PIK3CA—coronary artery disease	9.31e-07	3.36e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—IL6—coronary artery disease	8.62e-07	3.11e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—IL6—coronary artery disease	8.43e-07	3.04e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—IL6—coronary artery disease	8.25e-07	2.97e-05	CbGpPWpGaD
Penbutolol—ADRB1—Signaling Pathways—AKT1—coronary artery disease	7.95e-07	2.87e-05	CbGpPWpGaD
Penbutolol—ADRB2—Signaling Pathways—AKT1—coronary artery disease	7.78e-07	2.8e-05	CbGpPWpGaD
Penbutolol—HTR1A—Signaling Pathways—AKT1—coronary artery disease	7.61e-07	2.74e-05	CbGpPWpGaD
